Haemonetics, a Massachusetts-based innovator in blood and plasma technology, has filed a lawsuit against its Colorado-based competitor Terumo, alleging the infringement of four patents related to plasma collection systems. The contention involves two variations of Terumo’s donation systems, which received approval from the U.S. Food and Drug Administration in 2022 and 2024. The dispute highlights ongoing tensions in the competitive field of medical technology, where intellectual property rights are fiercely protected.
For further details on the legal claims and context, please refer to the report available on Law360, which provides in-depth coverage of this evolving legal battle.